Aptose Biosciences (TSE:APS) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$1.08 and traded as low as C$0.49. Aptose Biosciences shares last traded at C$0.50, with a volume of 8,575 shares trading hands.

Aptose Biosciences Price Performance

The company has a market capitalization of C$9.06 million, a PE ratio of -0.09 and a beta of 1.36. The company has a current ratio of 0.80, a quick ratio of 5.41 and a debt-to-equity ratio of 670.80. The company’s 50 day moving average price is C$0.56 and its 200-day moving average price is C$1.08.

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) last posted its quarterly earnings results on Thursday, August 8th. The biotechnology company reported C($0.59) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.80) by C$0.21. On average, sell-side analysts forecast that Aptose Biosciences Inc. will post -0.59 earnings per share for the current fiscal year.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.